Search

everythinglearnresearchcommunity

for

Search:↓

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

Lotion with fucoidan from brown seaweed improved skin and reduced allergy symptoms in mice with dermatitis.

Myrtle has various health benefits and potential for medicine development.

Hemp is a promising ingredient for skin products due to its healing and soothing properties.

Cannabidiol shows promise as an effective treatment for acne.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

The new nanocarriers improve how well water-insoluble drugs dissolve and allow for controlled drug release.

A man lost all his hair as a rare side effect after hepatitis C treatment.

A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Using hyaluronic acid fillers in the temple area of the face can improve looks but has risks, so choosing the right technique and product is important for safety.

A hepatitis B patient lost hair in patches after starting and stopping a treatment with pegylated interferon alpha2a.

Certain medications can cause serious side effects, so it's important to report them.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

A man with skin and hair symptoms improved partially with specific treatment.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

Various drugs caused different skin reactions, including allergic and inflammatory responses.

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

A patient developed a blister at the injection site after hepatitis C treatment.